Current News Market Watch Uncategorized

Tilray Signs Agreement with Leading Pharma Company Sandoz Canada

Tilray, wholly owned subsidiary of Privateer Holdings, has announced a partnership with one of the leading pharmaceutical companies in Canada called Sandoz Canada.

Under the terms of the signed agreement, Tilray  will gain exclusive rights to supply Sandoz Canada with non-combustible cannabis based medicines such as topicals and oral sprays. Sandoz Canada will distribute  product through their network of pharmacists, physicians, and patients across Canada.

Widening acknowledgment of cannabis products and its medicinal benefits is now prevalent in Canada. According to a report in September 2017 Health Canada, there are 235,621 registered medical marijuana in Canada. Tilray plans to develop new products for Sandoz Canada, which the company will then leverage to educate pharmacists and the public about the benefits of cannabis.

Related posts

OWC Pharmaceutical Research Corp. Reports Positive Safety Data From Phase 1 (Safety) Clinical Trial for Medical Grade Cannabis Ointment for Treatment of Skin Diseases


Willies Reserve, Cannabis Brand, Receives $12M in Funding


CBD Derived From Hemp Has Potential to Fight Ovarian Cancer Studies Find


Leave a Comment

%d bloggers like this: